Director/PDMR Share Purchases

RNS Number : 3642T

Cambridge Cognition Holdings PLC

22 July 2022

 

22 July 2022  

Cambridge Cognition Holdings Plc

("Cambridge Cognition", the "Company" or the "Group")

Director/PDMR Share Purchases

Cambridge Cognition Holdings Plc (AIM: COG), which develops and markets digital solutions to assess brain health, was informed on 21 July 2022 of the following purchases of the Company's ordinary shares by Directors and P DMRs of the Company .

The purchases made on 21 July 2022 are detailed in the table below:

Director/PDMR	No. of Ordinary Shares purchased	Purchase price per Ordinary Share	Total no. of Ordinary Shares held	Percentage ownership of total issued share capital
Matthew Stork	22,950	£1.13	147,950	0.47%
Stephen Symonds	22,950	£1.13	22,950	0.07%

Further information on the purchases is contained in the disclosure tables below.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

For further information, please contact:

Cambridge Cognition Holdings Plc	Tel: [phone]
Matthew Stork, Chief Executive Officer	[e-mail]
Stephen Symonds, Chief Financial Officer
Panmure Gordon (UK) Ltd (NOMAD and Joint Broker)	Tel: [phone]
Freddy Crossley / Emma Earl / Mark Rodgers	(Corporate Advisory)
Rupert Dearden	(Corporate Broking)
Dowgate Capital Limited (Joint Broker)	Tel: [phone]
David Poutney / James Serjeant
IFC Advisory Ltd (Financial PR and IR)	Tel: [phone]
Tim Metcalfe / Graham Herring / Zach Cohen	[e-mail]

Notes to Editors

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit  www.cambridgecognition.com

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Matthew Stork
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cambridge Cognition Holdings Plc
b)	LEI	213800SZKDIN122EPA96
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.01p each GB00B8DV9647
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £1.13 22,950
d)	Aggregated information - Aggregated volume - Price	22,950 £1.13
e)	Date of the transaction	21 July 2022
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Stephen Symonds
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cambridge Cognition Holdings Plc
b)	LEI	213800SZKDIN122EPA96
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.01p each GB00B8DV9647
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £1.13 22,950
d)	Aggregated information - Aggregated volume - Price	22,950 £1.13
e)	Date of the transaction	21 July 2022
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHPPURWMUPPGQG